Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02982759 · ClinicalTrials.gov registry record · NA
Together We STRIDE (Strategizing Together Relevant Interventions for Diet and Exercise)
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 888
- Enrollment target
NCT02982759: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT02982759 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 888 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02982759, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 888 participants
- Enrollment target
Study Summary
Obesity among Hispanic children in the Lower Yakima Valley of Washington State is alarmingly high. This study proposes to implement a comprehensive, multi-level intervention among children, families, the schools, and the community to combat this problem. The two year intervention will be measured by examining changes in children's body mass index.
Interventions
- BEHAVIORAL Multi-Level Intervention
- BEHAVIORAL Genetic Newsletters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 888 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-08-28 |
| Phase | NA |
What the finished NCT02982759 record still lists
NCT02982759 is an interventional study that assigns participants to a tested intervention. The registered 888 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 2 interventions - of which Multi-Level Intervention is the first listed.
NCT02982759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02982759 about?
NCT02982759 is a clinical study titled "Together We STRIDE (Strategizing Together Relevant Interventions for Diet and Exercise)". Obesity among Hispanic children in the Lower Yakima Valley of Washington State is alarmingly high. This study proposes to implement a comprehensive, multi-level intervention among children, families, the schools, and the community to combat this problem. The two year intervention will be measured by...
What is the current status of trial NCT02982759?
This trial is currently completed. It is a NA study. The enrollment target is 888 participants. The study started on 2016-04. Estimated completion is 2020-08-28.
What interventions are being tested in trial NCT02982759?
The interventions under investigation include: Multi-Level Intervention (BEHAVIORAL), Genetic Newsletters (BEHAVIORAL).
Who is sponsoring clinical trial NCT02982759?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02982759's enrollment target sits among peer trials
888 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03564340 · 890 participants · Phase 1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia